PURE
PURE BIOSCIENCE, INC.
Key Financials
Operating Income
$-2272000
↑ 28.8%
Revenue
$2.2M
↑ 12.4%
Gross Profit
$1.3M
↑ 13.1%
EPS (Diluted)
$-0.02
↑ 33.3%
Net Income
$-2399000
↑ 28.4%
Total Assets
$1.1M
↑ 29.3%
Total Liabilities
$6.2M
↑ 67.7%
Long-term Debt
$0.00
NaN%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 6/15/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| 10-Q | 3/17/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 8-K | 2/20/2026 | View on SEC |
| DEF 14A | 12/30/2025 | View on SEC |
| PRE 14A | 12/18/2025 | View on SEC |
| 10-Q | 12/15/2025 | View on SEC |
| 8-K | 12/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PURE |
| Company Name | PURE BIOSCIENCE, INC. |
| CIK | 1006028 |
| Sector | Miscellaneous Chemical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2890 |
| SIC Description | Miscellaneous Chemical Products |
| Entity Type | operating |
| Fiscal Year End | 0731 |
| State of Incorporation | DE |
| Phone | 619-596-8600 |